This content is machine translated Breast Cancer On the trail of triple-negative breast cancer Triple-negative breast cancer (TNBC) is a disease with an often aggressive course and a poor prognosis compared to other subtypes of breast cancer. It accounts for around 10-15% of all…
View Post 7 min This content is machine translated Breast Cancer News from the world of prevention, diagnosis and therapy Every year in December, around 7500 breast cancer experts from all over the world meet at the San Antonio Breast Cancer Symposium. The highlights of current breast cancer research on…
View Post 3 min This content is machine translated Breast Cancer HER2-negative breast cancer in a pot with triple-negative tumors? One study suggests that patients with low HR-positive/HER2-negative tumors could be considered and treated similarly to patients with triple-negative tumors. Should the current definitions of HR positivity and their clinical…
View Post 3 min This content is machine translated Breast Cancer From pathophysiology to new therapeutic strategies Breast cancer, the most common malignancy in women worldwide, is a very heterogeneous disease. The different molecular profiles can be divided into three main subtypes according to hormone receptor (ER…
View Post 4 min This content is machine translated Breast Cancer Improving treatment management: genetics in focus The genetics of breast cancer has become a fundamental aspect of treatment management. It influences screening, follow-up, prophylactic and therapeutic recommendations for women who carry a germinal breast cancer susceptibility…
View Post 6 min This content is machine translated Breast Cancer Latest findings around breast cancer research International experts have been meeting annually since 1977 to share current information on breast cancer research. The goal is to balance clinical, translational, and basic research and to provide a…
View Post 3 min This content is machine translated Breast Cancer New options in advanced breast cancer While new lecture formats had to be established due to the Corona pandemic, substantial progress in research around cancer therapies remained constant, as evidenced by study results presented at EHA.…
View Post 3 min This content is machine translated Breast Cancer Personalized medicine in the focus of treatment management The German Society for Senology (DGS) has been advocating for women’s breast health for a good four decades. The special feature of the professional society is its interdisciplinarity. To ensure…
View Post 9 min This content is machine translated Locally advanced/metastatic breast carcinoma 44th San Antonio Breast Cancer Symposium: Best Of From December 7-10, 2021, the 44th San Antonio Breast Cancer Symposium took place in a physical-virtual hybrid event. In a series of exciting lectures, the latest clinical and preclinical findings…
View Post 8 min This content is machine translated Advanced breast carcinoma What’s new? With antibody-drug conjugates, checkpoint and CDK4/6 inhibitors, three drug classes were in the spotlight at this year’s European Society for Medical Oncology (ESMO) congress in advanced breast cancer. This is…
View Post 4 min This content is machine translated Breast Cancer Metastatic pathways in focus Surgical or radiotherapeutic treatment of regional lymph nodes prolongs breast cancer survival and reduces the likelihood of distant metastasis. However, the effect on regional lymph node recurrence appears to be…
